PSU17 A Parametric Analysis of Overall Survival (OS) in Patients with Relapsed/Refractory (R/R) B-cell Acute Lymphoblastic Leukemia (ALL) Who Have Received Hematopoietic Stem Cell Transplant (HSCT)

Parametric Analysis ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem ◽

Cell Acute Lymphoblastic Leukemia

Hematopoietic stem cell transplant versus chemotherapy plus tyrosine kinase inhibitor in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL)

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2013.03.001 ◽

2013 ◽

Vol 6 (1) ◽

pp. 34-41 ◽

Cited By ~ 6

Author(s):

Khadra Salami ◽

Khaldoun Alkayed ◽

Hadeel Halalsheh ◽

Ayad Ahmed Hussein ◽

Maha Riziq ◽

...

Keyword(s):

Stem Cell ◽

Tyrosine Kinase Inhibitor ◽

Stem Cell Transplant ◽

Kinase Inhibitor ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Cell Transplant ◽

Should patients with acute lymphoblastic leukemia receive hematopoietic stem-cell transplant from an unrelated donor?

Nature Clinical Practice Oncology ◽

10.1038/ncponc0060 ◽

2005 ◽

Vol 2 (1) ◽

pp. 18-19

Author(s):

Stephen J Forman

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Unrelated Donor ◽

Cell Transplant ◽

Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor

Leukemia & Lymphoma ◽

10.3109/10428194.2014.914198 ◽

2014 ◽

Vol 56 (1) ◽

pp. 244-247 ◽

Cited By ~ 1

Author(s):

Emi Togasaki ◽

Katsuhiro Shono ◽

Masahiro Onoda ◽

Akira Yokota

Keyword(s):

Stem Cell ◽

Tyrosine Kinase Inhibitor ◽

Stem Cell Transplant ◽

Kinase Inhibitor ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Cell Transplant ◽

Real-World Use of First and Second Generation Tyrosine Kinase Inhibitors Pre- and Post-Hematopoietic Stem Cell Transplant in Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.07.033 ◽

2019 ◽

Vol 19 ◽

pp. S190

Author(s):

Radhika Takiar ◽

Anthony J. Perissinotti ◽

Bernard L. Marini ◽

Lydia Benitez-Colon ◽

Patrick W. Burke ◽

...

Keyword(s):

Stem Cell ◽

Kinase Inhibitors ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Philadelphia Chromosome ◽

Cell Transplant ◽

Hematopoietic Stem ◽

First And Second Generation

Voriconazole associated mucormycosis in a patient with relapsed acute lymphoblastic leukemia and hematopoietic stem cell transplant failure: A case report

Journal de Mycologie Médicale ◽

10.1016/j.mycmed.2018.05.008 ◽

2018 ◽

Vol 28 (3) ◽

pp. 527-530 ◽

Cited By ~ 1

Author(s):

A. Sharifpour ◽

N. Gholinejad-Ghadi ◽

R. Ghasemian ◽

Z. Seifi ◽

S.R. Aghili ◽

...

Keyword(s):

Stem Cell ◽

Case Report ◽

Hematopoietic Stem Cell ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem ◽

Transplant Failure

Blinatumomab As a Successful Bridge to Hematopoietic Stem Cell Transplant in a Down Syndrome Patient with Relapsed B-Precursor Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.538 ◽

2019 ◽

Vol 25 (3) ◽

pp. S333-S334

Author(s):

Mariel H. Smith ◽

Peter G. Steinherz ◽

Neerav Shukla ◽

Christopher J. Forlenza ◽

Susan E. Prockop ◽

...

Keyword(s):

Down Syndrome ◽

Stem Cell ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Cell Transplant ◽

Syndrome Patient ◽

Down Syndrome Patient ◽

ALL-073: Inotuzumab Ozogamicin (IO) and Donor Lymphocyte Infusion (DLI) are a Safe and Promising Combination in Relapsed Acute Lymphoblastic Leukemia (ALL) After Allogeneic Hematopoietic Stem Cell Transplant (HSCT)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(20)30678-9 ◽

2020 ◽

Vol 20 ◽

pp. S161

Author(s):

Cristina Papayannidis ◽

Chiara Sartor ◽

Alida Dominietto ◽

Elisabetta Zappone ◽

Giovanni Marconi ◽

...

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Donor Lymphocyte Infusion ◽

Cell Transplant ◽

Inotuzumab Ozogamicin ◽

To Transplant or Not? Weighing the Risks of Blinatumomab Prior to Hematopoietic Stem Cell Transplant in Acute Lymphoblastic Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2020.05.012 ◽

2020 ◽

Vol 26 (9) ◽

pp. e209-e210

Author(s):

Punita Grover ◽

Emily Curran

Keyword(s):

Stem Cell ◽

Hematopoietic Stem Cell ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Cell Transplant ◽

Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant

Leukemia & Lymphoma ◽

10.3109/10428194.2013.779691 ◽

2013 ◽

Vol 54 (11) ◽

pp. 2474-2479 ◽

Cited By ~ 15

Author(s):

Celalettin Eroglu ◽

Cigdem Pala ◽

Leylagül Kaynar ◽

Kadir Yaray ◽

M. Tarkan Aksozen ◽

...

Keyword(s):

Stem Cell ◽

Total Body Irradiation ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem ◽

Conditioning Regimens ◽

Total Body

The impact of post-hematopoietic stem cell transplant tyrosine kinase inhibitors in Philadelphia-positive acute lymphoblastic leukemia

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2021.07.003 ◽

2021 ◽

Author(s):

Khalid Halahleh ◽

Dalia Al Rimawi ◽

Amal Abu Ghosh ◽

Isra Muradi ◽

Waleed Da'na ◽

...

Keyword(s):

Stem Cell ◽

Tyrosine Kinase ◽

Kinase Inhibitors ◽

Stem Cell Transplant ◽

Lymphoblastic Leukemia ◽

Cell Transplant ◽

Hematopoietic Stem ◽

The Impact